Top

Published in:

01-12-2017 | Review

Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis

Authors: Gali H. Weissberger, Jessica V. Strong, Kayla B. Stefanidis, Mathew J. Summers, Mark W. Bondi, Nikki H. Stricker

Published in: Neuropsychology Review | Issue 4/2017

Abstract

With an increasing focus on biomarkers in dementia research, illustrating the role of neuropsychological assessment in detecting mild cognitive impairment (MCI) and Alzheimer’s dementia (AD) is important. This systematic review and meta-analysis, conducted in accordance with PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) standards, summarizes the sensitivity and specificity of memory measures in individuals with MCI and AD. Both meta-analytic and qualitative examination of AD versus healthy control (HC) studies (n = 47) revealed generally high sensitivity and specificity (≥ 80% for AD comparisons) for measures of immediate (sensitivity = 87%, specificity = 88%) and delayed memory (sensitivity = 89%, specificity = 89%), especially those involving word-list recall. Examination of MCI versus HC studies (n = 38) revealed generally lower diagnostic accuracy for both immediate (sensitivity = 72%, specificity = 81%) and delayed memory (sensitivity = 75%, specificity = 81%). Measures that differentiated AD from other conditions (n = 10 studies) yielded mixed results, with generally high sensitivity in the context of low or variable specificity. Results confirm that memory measures have high diagnostic accuracy for identification of AD, are promising but require further refinement for identification of MCI, and provide support for ongoing investigation of neuropsychological assessment as a cognitive biomarker of preclinical AD. Emphasizing diagnostic test accuracy statistics over null hypothesis testing in future studies will promote the ongoing use of neuropsychological tests as Alzheimer’s disease research and clinical criteria increasingly rely upon cerebrospinal fluid (CSF) and neuroimaging biomarkers.

Available only for authorised users

The selective reminding paradigm has been well described (see Carlesimo et al. 2011) and is best exemplified by the Free and Cued Selective Reminding Test (Grober and Buschke 1987). This paradigm attempts to control for encoding of material by providing the name of each semantic category (4 total) and asking subjects to point to each of 4 items within the semantic category. This is followed by immediate category cued recall (repeated until 4/4 items recalled). Next, individuals are asked to freely recall the items on the list. A category cued recall procedure is then used for any items not freely recalled. This procedure is typically repeated three times and provides a measure of free recall and total recall (free recall + cued recall).

A picture with two interacting pieces is presented (e.g., ape holding an umbrella) and individuals are asked to name both aspects of the picture. Immediately following presentation of six pictures, six cards are presented containing only one aspect of the picture (e.g., the ape alone). With presentation of the card missing an object, the individual is asked to say the item that is missing. Responses are accepted in any format: written, drawn, oral, or mimed.

Eight semantically or associatively unrelated word pairs (four concrete, e.g., horse-forest, and four abstract, e.g., open-fresh). Associate-Recognition task was always completed during the first and the Cued-Recall during the second session. After presentation of the eight pairs, in the Associate-Recognition phase, a cue was presented at the top of the page and individuals identified which from a list of 4 items had been presented with the cue. For the Cued-Recall phase, the cue was presented and the individual was asked to recall the word that had been paired with the cue.

A computerized task that displays boxes on the screen that are randomly opened. Some boxes contain a pattern. Patterns are then displayed in the middle of the screen and the individual must match the pattern in the middle of the screen to the appropriate location (i.e., box). When a mistake is made, the boxes are re-opened to remind the individual. The test becomes more difficult throughout and takes about 10 min to administer.

In the paper and pencil task, 10 faces and 10 objects were presented. The original version of the test showed faces in black and white whereas the novel version presented faces and objects in color. After encoding, individuals are immediately presented with the face or object (one at a time) and report in which quadrant of the page the item was originally presented. The total score is the number placed correctly out of 20. The computerized version was similar with an additional 10 shapes or 10 animals (30 items presented total) and participants were asked to click on the quadrant where the item had initially been presented. For both versions of the test, the 10 items belonging to a category were presented and tested separately, for example, encoding and testing phase of 10 faces followed by encoding and testing of 10 objects.

WMS Verbal Paired Associates (Wechsler 1945, VPA) (Spanish translation), individuals learned 10 pairs of words (6 related, 4 unrelated) across three trials, providing one score of total memory acquisition.

Individuals saw 2 or 3 items on the screen (difficulty varied depending on diagnosis; HC saw 3 items, AD patients saw 2 items) for 2000 ms during the study display. Following the study phase, individuals’ visual short-term memory was assessed for single feature and binding by using “color only” and “shape only” conditions in addition to “shape-color binding” conditions. In single feature conditions, new shapes or new colors were replaced in the test phase, respectively, so that memory for individual features was required to detect the change. In the shape-color binding condition, two shapes changed colors in the test phase compared to the study phase so that memory of both the bound shape and color elements was required to detect change.

This test examines associative memory of spatial location, event-place association, and place-object association memory.

During this test, participants are asked to re-create a 2 by 3 array of six simple geometric figures after three 10 s learning trials. Points are awarded for accuracy and correct object placement.

During this task participants are asked to recall the associated symbol of nine numbers that they initially learn through a coding task (WAIS-III Digit Symbol; (Wechsler 1997)).

Involves three time-based and three event-based prospective memory items embedded within puzzles of attention (Delprado et al. 2012). Two scores can be derived for this measure, an event-based score and a time-based score.

*Adam, S., Van der Linden, M., Ivanoiu, A., Juillerat, A. C., Bechet, S., & Salmon, E. (2007). Optimization of encoding specificity for the diagnosis of early AD: The RI-48 task. Journal of Clinical and Experimental Neuropsychology, 29(5), 477–487.

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 270–279.CrossRef

Alegret, M., Rodriguez, O., Espinosa, A., Ortega, G., Sanabria, A., Valero, S., et al. (2015). Concordance between subjective and objective memory impairment in volunteer subjects. Journal of Alzheimer's Disease, 48(4), 1109–1117.PubMedCrossRef

American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text Revision (DSMIV-TR) (IV ed.). Washington D.C: American Psychiatric Publishing, Inc.CrossRef

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub.

American Academy of Neurology. (1996). Assessment: Neuropsychological testing of adults. Considerations for neurologists. Neurology, 47, 592-599.

*Baek, M. J., Kim, H. J., Ryu, H. J., Lee, S. H., Han, S. H., Na, H. R., et al. (2011). The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease. Aging, Neuropsychology, and Cognition, 18(2), 214–229.CrossRef

Baek, M. J., Kim, H. J., & Kim, S. (2012). Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 34(4), 396–404.PubMedCrossRef

Beglinger, L. J., Duff, K., Moser, D. J., Cross, S. A., & Kareken, D. A. (2009). The Indiana faces in places test: Preliminary findings on a new Visuospatial memory test in patients with mild cognitive impairment. Archives of Clinical Neuropsychology, 24(6), 607.PubMedPubMedCentralCrossRef

Benedict, R. H. B. (1997). Brief Visuospatial memory test-revised. Lutz: Psychological Assessment Resources, Inc..

*Bertolucci, P. H. F., Okamoto, I. H., Brucki, S. M. D., Siviero, M. O., Toniolo Neto, J., & Ramos, L. R. (2001). Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arquivos de Neuro-Psiquiatria, 59(3A), 532–536.PubMedCrossRef

Binder, L. M., Iverson, G. L., & Brooks, B. L. (2009). To err is human:“abnormal” neuropsychological scores and variability are common in healthy adults. Archives of Clinical Neuropsychology, 24, 31–46.PubMedCrossRef

*Blanco-Campal, A., Coen, R. F., Lawlor, B. A., Walsh, J. B., & Burke, T. E. (2009). Detection of prospective memory deficits in mild cognitive impairment of suspected Alzheimer's disease etiology using a novel event-based prospective memory task. Journal of the International Neuropsychological Society, 15(1), 154–159.PubMedCrossRef

Bloudek, L. M., Spackman, D. E., Blankenburg, M., & Sullivan, S. D. (2011). Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease. Journal of Alzheimer's Disease, 26(4), 627–645.PubMed

Bondi, M. W., & Smith, G. E. (2014). Mild cognitive impairment: A concept and diagnostic entity in need of input from neuropsychology. Journal of the International Neuropsychological Society, 20(02), 129–134.PubMedPubMedCentralCrossRef

Bondi, M. W., Salmon, D. P., & Kaszniak, A. (1996). The neuropsychology of dementia. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (2nd ed., pp. 164–199). New York: Oxford.

Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., et al. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Journal of Alzheimer's Disease, 42(1), 275–289.PubMedPubMedCentral

Brooks, B. L., Iverson, G. L., & White, T. (2007). Substantial risk of “accidental MCI” in healthy older adults: Base rates of low memory scores in neuropsychological assessment. Journal of the International Neuropsychological Society, 13(03), 490–500.PubMedCrossRef

Busse, A., Hensel, A., Guhne, U., Angermeyer, M. C., & Riedel-Heller, S. G. (2006). Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology, 67(12), 2176–2185.PubMedCrossRef

*Cahn, D. A., Salmon, D. P., Butters, N., Wiederholt, W. C., Corey-Bloom, J., Edelstein, S. L., et al. (1995). Detection of dementia of the Alzheimer type in a population-based sample: Neuropsychological test performance. Journal of the International Neuropsychological Society, 1(3), 252–260.PubMedCrossRef

Calamia, M., Markon, K., & Tranel, D. (2013). The robust reliability of neuropsychological measures: Meta-analyses of test-retest correlations. The Clinical Neuropsychologist, 27(7), 1077–1105.PubMedCrossRef

Carlesimo, G. A., Perri, R., & Caltagirone, C. (2011). Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: A review of the evidence. Neuropsychology Review, 21(1), 54–65.PubMedCrossRef

*Chandler, M. J., Lacritz, L. H., Hynan, L. S., Barnard, H. D., Allen, G., Deschner, M., Weiner, M. F., & Cullum, C. M. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65(1), 102–106.

Chapman, K. R., Bing-Canar, H., Alosco, M. L., Steinberg, E. G., Martin, B., Chaisson, C., et al. (2016). Mini mental state examination and logical memory scores for entry into Alzheimer's disease trials. Alzheimer's Research & Therapy, 8, 9.

Chelune, G. J. (2010). Evidence-based research and practice in clinical neuropsychology. The Clinical Neuropsychologist, 24(3), 454–467.PubMedCrossRef

*Clark, J. H., Hobson, V. L., & O'Bryant, S. E. (2010). Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment. Archives of Clinical Neuropsychology, 25(4), 318–326.PubMedCrossRef

Clark, L. R., Delano-Wood, L., Libon, D. J., McDonald, C. R., Nation, D. A., Bangen, K. J., et al. (2013). Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes? Journal of the International Neuropsychological Society, 19(06), 635–645.PubMedPubMedCentralCrossRef

*Crocco, E., Curiel, R. E., Acevedo, A., Czaja, S. J., & Loewenstein, D. A. (2014). An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease. The American Journal of Geriatric Psychiatry, 22(9), 889–897.PubMedCrossRef

Davis, D., Schmitt, F., Wekstein, D., & Markesbery, W. (1999). Alzheimer neuropathologic alterations in aged cognitively normal subjects. Journal of Neuropathology & Experimental Neurology, 58(4), 376–388.CrossRef

*de Jager, C. A., Hogervorst, E., Combrinck, M., & Budge, M. M. (2003). Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychological Medicine, 33(6), 1039–1050.PubMedCrossRef

*Delgado, C., Munoz-Neira, C., Soto, A., Martinez, M., Henriquez, F., Flores, P., et al. (2016). Comparison of the psychometric properties of the "word" and "picture" versions of the free and cued selective reminding test in a Spanish-speaking cohort of patients with mild Alzheimer's disease and cognitively healthy controls. Archives of Clinical Neuropsychology, 31(2), 165–175.PubMed

Delis, D. C., Massman, P. J., Butters, N., Salmon, D. P., Cermak, L. S., & Kramer, J. H. (1991). Profiles of demented and amnesic patients on the California verbal learning test: Implications for the assessment of memory disorders. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 3(1), 19.CrossRef

Delis, D. C., Wetter, S. R., Jacobson, M. W., Peavy, G., Hamilton, J., Gongvatana, A., et al. (2005). Recall discriminability: Utility of a new CVLT-II measure in the differential diagnosis of dementia. Journal of the International Neuropsychological Society, 11(6), 708–715.PubMedCrossRef

*Delprado, J., Kinsella, G., Ong, B., Pike, K., Ames, D., Storey, E., et al. (2012). Clinical measures of prospective memory in amnestic mild cognitive impairment. Journal of the International Neuropsychological Society, 18(2), 295–304.PubMedCrossRef

Dennis, M. L., Lennox, M. A., & Foss, M. A. (1997). Practical power analysis for substance abuse health services research. In K. Bryant, M. Windle, & S. G. West (Eds.), The science of prevention: Methodological advances from alcohol and substance abuse research (pp. 367–404). Washington DC: American Psychological Association.CrossRef

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.PubMedCrossRef

Devanand, D. P., Liu, X., Tabert, M. H., Pradhaban, G., Cuasay, K., Bell, K., et al. (2008). Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry, 64(10), 871–879.PubMedPubMedCentralCrossRef

Doebler, P. (2015). MADA: Meta-analysis of diagnostic accuracy. Available from: cran. r-project. org/web/packages/mada/vignettes/mada. pdf. R package version 0.5. 7.

Doebler, P., & Holling, H. (2015). Meta-analysis of diagnostic accuracy with mada. Retrieved at: https://cran. rproject. org/web/packages/mada/vignettes/mada. pdf.

Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., et al. (2007). Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology, 6(8), 734–746.PubMedCrossRef

Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., Dekosky, S. T., Barberger-Gateau, P., et al. (2010). Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurology, 9(11), 1118–1127.PubMedCrossRef

Ducharme, S., Guiot, M.-C., Nikelski, J., & Chertkow, H. (2013). Does a positive Pittsburgh compound B scan in a patient with dementia equal Alzheimer disease? JAMA Neurology, 70(7), 912–914.PubMedCrossRef

*Duff, K., Humphreys Clark, J. D., O'Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: Sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology, 23(5), 603–612.PubMedPubMedCentralCrossRef

*Duff, K., Hobson, V. L., Beglinger, L. J., & O'Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology, 25(5), 429–441.PubMedPubMedCentralCrossRef

Eckerström, C., Olsson, E., Bjerke, M., Malmgren, H., Edman, Å., Wallin, A., et al. (2013). A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. Journal of Alzheimer's Disease, 36(3), 421–431.PubMed

Edison, P., Rowe, C. C., Rinne, J. O., Ng, S., Ahmed, I., Kemppainen, N., et al. (2008). Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C] PIB positron emission tomography. Journal of Neurology, Neurosurgery & Psychiatry, 79(12), 1331–1338.CrossRef

Edmonds, E. C., Delano-Wood, L., Clark, L. R., Jak, A. J., Nation, D. A., McDonald, C. R., et al. (2015a). Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimer's & Dementia, 11, 415–424.CrossRef

Edmonds, E. C., Delano-Wood, L., Galasko, D., Salmon, D. P., & Bondi, M. W. (2015b). Subtle cognitive decline and biomarker staging in preclinical Alzheimer's disease. Journal of Alzheimer's Disease, 47, 231–242.PubMedPubMedCentralCrossRef

Ellis, P. D. (2010). The essential guide to effect sizes: Statistical power, meta-analysis, and the interpretation of research results. Cambridge: Cambridge University press.CrossRef

*Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M., Petersen, R. C., Jack Jr., C. R., et al. (2012). Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiology of Aging, 33(7), 1203–1214.PubMedCrossRef

Fields, J. A., Ferman, T. J., Boeve, B. F., & Smith, G. E. (2011). Neuropsychological assessment of patients with dementing illness. Nature Reviews. Neurology, 7(12), 677–687.PubMedCrossRef

Fischer, P., Jungwirth, S., Zehetmayer, S., Weissgram, S., Hoenigschnabl, S., Gelpi, E., et al. (2007). Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology, 68(4), 288–291.PubMedCrossRef

Gainotti, G., Quaranta, D., Vita, M. G., & Marra, C. (2014). Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. Journal of Alzheimer's Disease, 38(3), 481–495.PubMed

Ganguli, M., Snitz, B. E., Saxton, J. A., Chang, C.-C. H., Lee, C.-W., Vander Bilt, J., et al. (2011). Outcomes of mild cognitive impairment by definition: A population study. Archives of Neurology, 68(6), 761–767.PubMedPubMedCentralCrossRef

*Gavett, B. E., Poon, S. J., Ozonoff, A., Jefferson, A. L., Nair, A. K., Green, R. C., et al. (2009). Diagnostic utility of the NAB list learning test in Alzheimer's disease and amnestic mild cognitive impairment. Journal of the International Neuropsychological Society, 15(1), 121–129.PubMedPubMedCentralCrossRef

Gavett, B. E., Lou, K. R., Daneshvar, D. H., Green, R. C., Jefferson, A. L., & Stern, R. A. (2012). Diagnostic accuracy statistics for seven neuropsychological assessment battery (NAB) test variables in the diagnosis of Alzheimer's disease. Appl Neuropsychol Adult, 19(2), 108–115.PubMedCrossRef

Gomar, J. J., Conejero-Goldberg, C., Davies, P., Goldberg, T. E., & Initiative, A. s. D. N. (2014). Extension and refinement of the predictive value of different classes of markers in ADNI: Four-year follow-up data. Alzheimer's & Dementia, 10(6), 704–712.CrossRef

*Gonzalez-Palau, F., Franco, M., Jimenez, F., Parra, E., Bernate, M., & Solis, A. (2013). Clinical utility of the hopkins verbal test-revised for detecting Alzheimer's disease and mild cognitive impairment in Spanish population. Archives of Clinical Neuropsychology, 28(3), 245–253.

Graham, N. L., Emery, T., & Hodges, J. R. (2004). Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 75(1), 61–71.PubMedPubMedCentral

Grober, E., & Buschke, H. (1987). Genuine memory deficits in dementia. Developmental Neuropsychology, 3(1), 13–36.CrossRef

Growdon, J., Selkoe, D. J., Roses, A. D., et al. (1998). The Ronald and Nancy Reagan research Institute of the Alzheimer’s association and the National Institute on Aging working group. Consensus report of the working group on: molecular and biochemical markers of Alzheimer’s disease. Neurobiology of Aging, 19(2), 109–116.

Han, J. W., Kim, T. H., Lee, S. B., Park, J. H., Lee, J. J., Huh, Y., et al. (2012). Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement, 8(6), 553–559.PubMedCrossRef

Han, S. D., Nguyen, C. P., Stricker, N. H., & Nation, D. A. (2017). Detectable neuropsychological differences in early preclinical Alzheimer's disease: A meta-analysis. Neuropsychology Review. https://doi.org/10.1007/s11065-017-9345-5.

Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353–356.PubMedCrossRef

Heister, D., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, A. s. D. N. (2011). Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology, 77(17), 1619–1628.PubMedPubMedCentralCrossRef

Herrup, K. (2015). The case for rejecting the amyloid cascade hypothesis. Nature Neuroscience, 18, 794–799.

*Hogervorst, E., Combrinck, M., Lapuerta, P., Rue, J., Swales, K., & Budge, M. (2002). The Hopkins verbal learning test and screening for dementia. Dementia and Geriatric Cognitive Disorders, 13(1), 13–20.

*Ivanoiu, A., Adam, S., Linden, M., Salmon, E., Juillerat, A.-C., Mulligan, R., & Seron, X. (2005). Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease. Journal of Neurology, 252(1), 47–55.

*Ivnik, R. J., Smith, G. E., Petersen, R. C., Boeve, B. F., Kokmen, E., & Tangalos, E. G. (2000). Diagnostic accuracy of four approaches to interpreting neuropsychological test data. Neuropsychology, 14(2), 163–177.PubMedCrossRef

Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., et al. (2011). Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 257–262.CrossRef

Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Giovanni, B., et al. (2016). A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539–547.PubMedPubMedCentralCrossRef

Jak, A. J., Bondi, M. W., Delano-Wood, L., Wierenga, C., Corey-Bloom, J., Salmon, D. P., et al. (2009). Quantification of five neuropsychological approaches to defining mild cognitive impairment. The American Journal of Geriatric Psychiatry, 17(5), 368–375.PubMedPubMedCentralCrossRef

Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., et al. (2013a). Appropriate use criteria for amyloid PET: A report of the amyloid imaging task force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s association. Journal of Nuclear Medicine, 54(3), 476–490.PubMedCrossRef

Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., et al. (2013b). Appropriate use criteria for amyloid PET: A report of the amyloid imaging task force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement, 9(1), e-1–e16.CrossRef

*Junkkila, J., Oja, S., Laine, M., & Karrasch, M. (2012). Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 34(2), 83–89.PubMedCrossRef

Kanne, S. M., Balota, D. A., Storandt, M., McKeel Jr., D. W., & Morris, J. C. (1998). Relating anatomy to function in Alzheimer's disease: Neuropsychological profiles predict regional neuropathology 5 years later. Neurology, 50(4), 979–985.PubMedCrossRef

*Karantzoulis, S., Novitski, J., Gold, M., & Randolph, C. (2013). The repeatable battery for the assessment of neuropsychological status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease. Archives of Clinical Neuropsychology, 28(8), 837–844.PubMedCrossRef

Karrasch, M., Sinerva, E., Gronholm, P., Rinne, J., & Laine, M. (2005). CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurologica Scandinavica, 111(3), 172–179.PubMedCrossRef

Kim, K. W., Lee, J., Choi, S. H., Huh, J., & Park, S. H. (2015). Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers-part I. General guidance and tips. Korean Journal of Radiology, 16(6), 1175–1187.PubMedPubMedCentralCrossRef

Klekociuk, S., Summers, J., Vickers, J., & Summers, M. J. (2014). Reducing false positive diagnoses in mild cognitive impairment: The importance of comprehensive neuropsychological assessment. European Journal of Neurology, 21(10), 1330–e1383.PubMedCrossRef

Laforce, R., & Rabinovici, G. D. (2011). Amyloid imaging in the differential diagnosis of dementia: Review and potential clinical applications. Alzheimer's Research & Therapy, 3(6), 1.CrossRef

*Kuslansky, G., Katz, M., Verghese, J., Hall, C. B., Lapuerta, P., LaRuffa, G., & Lipton, R. B. (2004). Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination. Archives of Clinical Neuropsychology, 19(1), 89–104.

Landau, S., Harvey, D., Madison, C., Reiman, E., Foster, N., Aisen, P., et al. (2010). Comparing predictors of conversion and decline in mild cognitive impairment. Neurology, 75(3), 230–238.PubMedPubMedCentralCrossRef

Lee, J., Kim, K. W., Choi, S. H., Huh, J., & Park, S. H. (2015). Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers-part II. Statistical methods of meta-analysis. Korean Journal of Radiology, 16(6), 1188–1196.PubMedPubMedCentralCrossRef

*Lehrner, J., Maly, J., Gleiß, A., Auff, E., & Dal-Bianco, P. (2007). Demenzdiagnostik mit Hilfe der Vienna Neuropsychologischen Testbatterie (VNTB): Standardisierung, Normierung und Validierung. Psychologie in Österreich, 4&5, 358–365.

*Lekeu, F., Magis, D., Marique, P., Delbeuck, X., Bechet, S., Guillaume, B., et al. (2010). The California verbal learning test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia. Journal of Clinical and Experimental Neuropsychology, 32(2), 164–173.PubMedCrossRef

*Lemos, R., Duro, D., Simões, M. R., & Santana, I. (2014). The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease. Archives of Clinical Neuropsychology, 29(7), 670–679.PubMedPubMedCentralCrossRef

*Lemos, R., Simoes, M. R., Santiago, B., & Santana, I. (2015). The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease. Journal of Neuropsychology, 9(2), 242–257.PubMedCrossRef

Lin, J. S., O'Connor, E., Rossom, R. C., Perdue, L. A., Burda, B. U., Thompson, M., et al. (2013). “U.S. Preventive Services Task Force evidence syntheses, formerly systematic evidence reviews,” in Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality (US), Rockville, Md.

Lindeboom, J., Schmand, B., Tulner, L., Walstra, G., & Jonker, C. (2002). Visual association test to detect early dementia of the Alzheimer type. Journal of Neurology, Neurosurgery, and Psychiatry, 73(2), 126–133.PubMedPubMedCentralCrossRef

Lineweaver, T. T., Bondi, M. W., Galasko, D., & Salmon, D. P. (2014). Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. American Journal of Psychiatry, 171(2), 201–208.

*Loewenstein, D. A., Acevedo, A., Luis, C., Crum, T., Barker, W. W., & Duara, R. (2004). Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia. Journal of the International Neuropsychological Society, 10(1), 91–100.PubMedCrossRef

*Loewenstein, D. A., Acevedo, A., Ownby, R., Agron, J., Barker, W. W., Isaacson, R., et al. (2006). Using different memory cutoffs to assess mild cognitive impairment. The American Journal of Geriatric Psychiatry, 14(11), 911–919.PubMedCrossRef

Looi, J. C., & Sachdev, P. S. (1999). Differentiation of vascular dementia from AD on neuropsychological tests. Neurology, 53(4), 670–678.PubMedCrossRef

Lowndes, G., & Savage, G. (2007). Early detection of memory impairment in Alzheimer’s disease: A neurocognitive perspective on assessment. Neuropsychology Review, 17(3), 193–202.PubMedCrossRef

Lowndes, G. J., Saling, M. M., Ames, D., Chiu, E., Gonzalez, L. M., & Savage, G. R. (2008). Recall and recognition of verbal paired associates in early Alzheimer's disease. Journal of the International Neuropsychological Society, 14(4), 591–600.PubMedCrossRef

Lundervold, A. J., Reinvang, I., & Lundervold, A. (1994). Characteristic patterns of verbal memory function in patients with Huntington's disease. Scandinavian Journal of Psychology, 35(1), 38–47.PubMedCrossRef

Macaskill, P., Gatsonis, C., Deeks, J. J., Harbord, R. M., & Takwoingi, Y. (2009). Chapter 10: Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0.

Marcone, S., Gagnon, J. F., Lecomte, S., Imbeault, H., Limoges, F., Postuma, R. B., et al. (2017). Clinical utility of the envelope task in mild cognitive impairment and dementia. The Canadian Journal of Neurological Sciences, 44(1), 9–16.PubMedCrossRef

Matioli, M. N. P., & Caramelli, P. (2010). Limitations in differentiating vascular dementia from Alzheimer's disease with brief cognitive tests. Arquivos de Neuro-Psiquiatria, 68(2), 185–188.PubMedCrossRef

McDermott, A. T., & DeFilippis, N. A. (2010). Are the indices of the RBANS sufficient for differentiating Alzheimer's disease and subcortical vascular dementia? Archives of Clinical Neuropsychology, 25(4), 327–334.PubMedCrossRef

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.PubMedCrossRef

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack Jr., C. R., Kawas, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 263–269.PubMedPubMedCentralCrossRef

Mitchell, A. J., & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119(4), 252–265.PubMedCrossRef

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.PubMedCrossRef

Naslund, J., Haroutunian, V., Mohs, R., Davis, K. L., Davies, P., Greengard, P., et al. (2000). Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA, 283(12), 1571–1577.PubMedCrossRef

Noel-Storr, A. H., McCleery, J. M., Richard, E., Ritchie, C. W., Flicker, L., Cullum, S. J., et al. (2014). Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem initiative. Neurology, 83(4), 364–373.PubMedPubMedCentralCrossRef

O'Carroll, R., Conway, S., Ryman, A., & Prentice, N. (1997). Performance on the delayed word recall test (DWR) fails to differentiate clearly between depression and Alzheimer's disease in the elderly. Psychological Medicine, 27(4), 967–971.PubMedCrossRef

O'Connell, M. E., & Tuokko, H. (2010). Age corrections and dementia classification accuracy. Archives of Clinical Neuropsychology, 25(2), 126–138.PubMedCrossRef

O'Connell, H., Coen, R., Kidd, N., Warsi, M., Chin, A. V., & Lawlor, B. A. (2004). Early detection of Alzheimer's disease (AD) using the CANTAB paired associates learning test. International Journal of Geriatric Psychiatry, 19(12), 1207–1208.PubMedCrossRef

Oda, H., Yamamoto, Y., & Maeda, K. (2009). The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 24(2), 125–131.PubMedCrossRef

Palmqvist, S., Hertze, J., Minthon, L., Wattmo, C., Zetterberg, H., Blennow, K., et al. (2012). Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer’s disease in mild cognitive impairment: Six-year follow-up study. PloS One, 7(6), e38639.PubMedPubMedCentralCrossRef

*Park, S., Kim, I., Park, H. G., Shin, S. A., Cho, Y., Youn, J. H., et al. (2016). Development and validation of the rappel Indice-24: Behavioral and brain morphological evidence. Journal of Geriatric Psychiatry and Neurology, 29(3), 160–168.PubMedCrossRef

*Parra, M. A., Abrahams, S., Logie, R. H., Mendez, L. G., Lopera, F., & Della Sala, S. (2010). Visual short-term memory binding deficits in familial Alzheimer's disease. Brain, 133(9), 2702–2713.PubMedCrossRef

Parra, M. A., Sala, S. D., Abrahams, S., Logie, R. H., Mendez, L. G., & Lopera, F. (2011). Specific deficit of colour-colour short-term memory binding in sporadic and familial Alzheimer's disease. Neuropsychologia, 49(7), 1943–1952.PubMedCrossRef

*Parra, M. A., Ascencio, L. L., Urquina, H. F., Manes, F., & Ibanez, A. M. (2012). P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia. Frontiers in Neurology, 3, 172.PubMedPubMedCentralCrossRef

*Paulsen, J. S., Salmon, D. P., Monsch, A. U., Butters, N., Swenson, M. R., & Bondi, M. W. (1995). Discrimination of cortical from subcortical dementias on the basis of memory and problem-solving tests. Journal of Clinical Psychology, 51(1), 48–58.PubMedCrossRef

*Pengas, G., Patterson, K., Arnold, R. J., Bird, C. M., Burgess, N., & Nestor, P. J. (2010). Lost and found: Bespoke memory testing for Alzheimer's disease and semantic dementia. Journal of Alzheimer's Disease, 21(4), 1347–1365.PubMedCrossRef

Perani, D., Schillaci, O., Padovani, A., Nobili, F., Iaccarino, L., Della Rosa, P., et al. (2013). A survey of FDG-and amyloid-PET imaging in dementia and GRADE analysis. BioMed Research International, 2014, 785039–785039.

Peters, F., Villeneuve, S., & Belleville, S. (2014). Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors. Journal of Alzheimer's Disease, 38(2), 307–318.PubMed

Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194.PubMedCrossRef

Petersen, R. (2007). Mild cognitive impairment. Continuum: Lifelong learning in neurology, 13 (2). Dementia, 15–38.

Petersen, R., & Kanow, C. (2001). Mild cognitive impairment-state of the art 2001. REVUE NEUROLOGIQUE, 157(10; SUPP), 4S29-24S29.

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303–308.PubMedCrossRef

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., et al. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58(12), 1985–1992.PubMedCrossRef

Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., et al. (2009). Mild cognitive impairment: Ten years later. Archives of Neurology, 66(12), 1447–1455.PubMedPubMedCentralCrossRef

Petersen, R. C., Aisen, P., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Knopman, D. S., et al. (2013). Mild cognitive impairment due to Alzheimer disease in the community. Annals of Neurology, 74(2), 199–208.PubMedPubMedCentral

*Pike, K. E., Kinsella, G. J., Ong, B., Mullaly, E., Rand, E., Storey, E., et al. (2013). Is the WMS-IV verbal paired associates as effective as other memory tasks in discriminating amnestic mild cognitive impairment from normal aging? The Clinical Neuropsychologist, 27(6), 908–923.PubMedCrossRef

Portet, F., Ousset, P. J., Visser, P. J., Frisoni, G. B., Nobili, F., Scheltens, P., et al. (2006). Mild cognitive impairment (MCI) in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI working Group of the European Consortium on Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 77(6), 714–718.PubMedPubMedCentralCrossRef

*Rabin, L. A., Pare, N., Saykin, A. J., Brown, M. J., Wishart, H. A., Flashman, L. A., et al. (2009). Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition, 16(3), 357–376.PubMedPubMedCentralCrossRef

Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., et al. (2005). Conversion of mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dementia and Geriatric Cognitive Disorders, 21(1), 51–58.PubMedCrossRef

Reitsma, J. B., Rutjes, A. W. S., Whiting, P., Vlassov, V. V., Leeflang, M. M. G., & Deeks, J. J. (2009). Chapter 9: Assessing methodological quality. Cochrane handbook for systematic reviews of diagnostic test accuracy version, 1(0), 1–27.

Rentz, D. M., Parra Rodriguez, M. A., Amariglio, R., Stern, Y., Sperling, R., & Ferris, S. (2013). Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: A selective review. Alzheimer's Research & Therapy, 5(6), 58.CrossRef

*Ritter, E., Despres, O., Monsch, A. U., & Manning, L. (2006). Topographical recognition memory sensitive to amnestic mild cognitive impairment but not to depression. International Journal of Geriatric Psychiatry, 21(10), 924–929.PubMedCrossRef

Saka, E., & Elibol, B. (2009). Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction. Parkinsonism & Related Disorders, 15(9), 688–691.CrossRef

Saka, E., Mihci, E., Topcuoglu, M. A., & Balkan, S. (2006). Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people. Archives of Clinical Neuropsychology, 21(7), 745–751.PubMedCrossRef

Salmon, D. P., Granholm, E., McCullough, D., Butters, N., & Grant, I. (1989). Recognition memory span in mildly and moderately demented patients with Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 11(4), 429–443.PubMedCrossRef

*Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., et al. (2002). Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology, 59(7), 1022–1028.PubMedCrossRef

Schmidtke, K., & Hüll, M. (2002). Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. Journal of the Neurological Sciences, 203, 17–22.PubMedCrossRef

*Schrijnemaekers, A. M., de Jager, C. A., Hogervorst, E., & Budge, M. M. (2006). Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. Journal of Clinical and Experimental Neuropsychology, 28(3), 438–455.

Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009). The neuropathology of probable Alzheimer disease and mild cognitive impairment. Annals of Neurology, 66(2), 200–208.PubMedPubMedCentralCrossRef

Schwarzer, G., Carpenter, J. R., & Rücker, G. (2015). Meta-analysis with R. New York, NY: Springer.

*Serna, A., Contador, I., Bermejo-Pareja, F., Mitchell, A. J., Fernández-Calvo, B., Ramos, F., et al. (2015). Accuracy of a brief neuropsychological battery for the diagnosis of dementia and mild cognitive impairment: An analysis of the NEDICES cohort. Journal of Alzheimer's Disease, 48, 163–173.PubMedCrossRef

*Shankle, W. R., Romney, A. K., Hara, J., Fortier, D., Dick, M. B., Chen, J. M., et al. (2005). Methods to improve the detection of mild cognitive impairment. Proceedings of the National Academy of Sciences of the United States of America, 102(13), 4919–4924.PubMedPubMedCentralCrossRef

*Shi, J., Tian, J., Wei, M., Miao, Y., & Wang, Y. (2012). The utility of the Hopkins verbal learning test (Chinese version) for screening dementia and mild cognitive impairment in a Chinese population. BMC Neurology, 12, 136.PubMedPubMedCentralCrossRef

*Shi, J., Wei, M., Tian, J., Snowden, J., Zhang, X., Ni, J., et al. (2014). The Chinese version of story recall: A useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly. Biomed Central Psychiatry, 14(71), 1–10.

Smith, G. E., Ivnik, R. I., & Lucas, J. (2008). Assessment techniques: Tests, test batteries, norms, and methodological approaches. In J. E. Morgan & J. H. Ricker (Eds.), Textbook of clinical neuropsychology (pp. 38–58). New York: Taylor & Francis Group.

*Sotaniemi, M., Pulliainen, V., Hokkanen, L., Pirttila, T., Hallikainen, I., Soininen, H., et al. (2012). CERAD-neuropsychological battery in screening mild Alzheimer's disease. Acta Neurologica Scandinavica, 125(1), 16–23.PubMedCrossRef

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 280–292.CrossRef

*Storandt, M., & Morris, J. C. (2010). Ascertainment bias in the clinical diagnosis of Alzheimer disease. Archives of Neurology, 67(11), 1364–1369.PubMedPubMedCentralCrossRef

Summers, M. J., & Saunders, N. L. (2012). Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment. Neuropsychology, 26(4), 498.PubMedCrossRef

*Takechi, H., & Dodge, H. H. (2010). Scenery picture memory test: A new type of quick and effective screening test to detect early stage Alzheimer's disease patients. Geriatrics & Gerontology International, 10(2), 183–190.

*Testa, J. A., Ivnik, R. J., Boeve, B., Petersen, R. C., Pankratz, V. S., Knopman, D., et al. (2004). Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease. Journal of the International Neuropsychological Society, 10(4), 504–512.PubMedCrossRef

Tierney, M. C., Black, S. E., Szalai, J. P., Snow, W. G., Fisher, R. H., Nadon, G., et al. (2001). Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Archives of Neurology, 58(10), 1654–1659.PubMedCrossRef

Troster, A. I., Butters, N., Salmon, D. P., Cullum, C. M., Jacobs, D., Brandt, J., et al. (1993). The diagnostic utility of savings scores: Differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests. Journal of Clinical and Experimental Neuropsychology, 15(5), 773–788.PubMedCrossRef

*Thompson, T. A. C., Wilson, P. H., Snyder, P. J., Pietrzak, R. H., Darby, D., Maruff, P., & Buschke, H. (2011). Sensitivity and Test-Retest Reliability of the International Shopping List Test in Assessing Verbal Learning and Memory in Mild Alzheimer's Disease. Archives of Clinical Neuropsychology, 26(5), 412–424.

Troyer, A. K., Murphy, K. J., Anderson, N. D., Hayman-Abello, B. A., Craik, F. I., & Moscovitch, M. (2008). Item and associative memory in amnestic mild cognitive impairment: Performance on standardized memory tests. Neuropsychology, 22(1), 10–16.PubMedCrossRef

Troyer, A. K., Murphy, K. J., Anderson, N. D., Craik, F. I., Moscovitch, M., Maione, A., et al. (2012). Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E. Neuropsychologia, 50(14), 3721–3728.PubMedCrossRef

Turriziani, P., Fadda, L., Caltagirone, C., & Carlesimo, G. A. (2004). Recognition memory for single items and for associations in amnesic patients. Neuropsychologia, 42(4), 426–433.PubMedCrossRef

US Dept of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. (2013). Alzheimer’s disease: developing drugs for the treatment of early stage disease (draft guidance). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338287.pdf.

Vacante, M., Wilcock, G. K., & de Jager, C. A. (2013). Computerized adaptation of the placing test for early detection of both mild cognitive impairment and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 35(8), 846–856.PubMedCrossRef

*Vogel, A., Mortensen, E. L., Gade, A., & Waldemar, G. (2007). The category cued recall test in very mild Alzheimer's disease: Discriminative validity and correlation with semantic memory functions. European Journal of Neurology, 14(1), 102–108.

Wang, H. M., Yang, C. M., Kuo, W. C., Huang, C. C., & Kuo, H. C. (2013). Use of a modified spatial-context memory test to detect amnestic mild cognitive impairment. PloS One, 8(2), e57030.PubMedPubMedCentralCrossRef

Wechsler, D. (1945) A Standardized Memory Scale for Clinical Use. The Journal of Psychology, 19(1), 87-95, https://doi.org/10.1080/00223980.1945.9917223

Wechsler, D. (1997). WAIS-III: Administration and scoring manual: Wechsler adult intelligence scale: Psychological corporation. San Antonio, TX.

*Welsh, K., Butters, N., Hughes, J., Mohs, R., & Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology, 48(3), 278–281.PubMedCrossRef

Whiting, P. F., Rutjes, A. W., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., et al. (2011). QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine, 155(8), 529–536.PubMedCrossRef

Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment--beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment. Journal of Internal Medicine, 256(3), 240–246.PubMedCrossRef

Yaffe, K., Petersen, R. C., Lindquist, K., Kramer, J., & Miller, B. (2006). Subtype of mild cognitive impairment and progression to dementia and death. Dementia and Geriatric Cognitive Disorders, 22(4), 312–319.PubMedCrossRef

Yassuda, M. S., Flaks, M. K., Viola, L. F., Pereira, F. S., Memoria, C. M., Nunes, P. V., et al. (2010). Psychometric characteristics of the Rivermead Behavioural memory test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil. International Psychogeriatrics, 22(6), 1003–1011.PubMedCrossRef

Yonelinas, A. P., Hopfinger, J. B., Buonocore, M. H., Kroll, N. E., & Baynes, K. (2001). Hippocampal, parahippocampal and occipital-temporal contributions to associative and item recognition memory: An fMRI study. Neuroreport, 12(2), 359–363.PubMedCrossRef

Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., et al. (2014). 11C–PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev, 7, CD010386.

Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature Reviews Neuroscience, 12(12), 723–738.PubMedPubMedCentralCrossRef

Title: Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis
Authors: Gali H. Weissberger
Jessica V. Strong
Kayla B. Stefanidis
Mathew J. Summers
Mark W. Bondi
Nikki H. Stricker
Publication date: 01-12-2017
Publisher: Springer US
Published in: Neuropsychology Review / Issue 4/2017
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-017-9360-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Is Obstructive Sleep Apnoea Related to Neuropsychological Function in Healthy Older Adults? A Systematic Review and Meta-Analysis

The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures

Editorial Introduction to the Special Issue on Neuropsychological Assessment in Aging

Cognitive Interventions for Cognitively Healthy, Mildly Impaired, and Mixed Samples of Older Adults: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials

Detectable Neuropsychological Differences in Early Preclinical Alzheimer’s Disease: A Meta-Analysis

Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis